N-(4-[18F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT1A receptors

被引：6
|
作者：
Garcia, Gonzalo [1 ]
Abet, Valentina [1 ]
Alajarin, Ramon [1 ]
Alvarez-Builla, Julio [1 ]
Delgado, Mercedes [2 ]
Garcia-Garcia, Luis [2 ]
Bascunana-Almarcha, Pablo [2 ]
Pena-Salcedo, Carmen [3 ]
Kelly, James [3 ]
Pozo, Miguel A. [2 ,3 ]
机构：
[1] Univ Alcala, Dept Quim Organ, Madrid 28871, Spain
[2] Inst Pluridisciplinar UCM, CAI Cartog Cerebral, Madrid 28040, Spain
[3] Inst Tecnol PET, Madrid 28040, Spain
来源：
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 2014年 / 85卷
关键词：
5-HT1A; Positron emission tomography; Fluorine-18; Radioligand; N-(4-[F-18]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides; NUCLEOPHILIC AROMATIC-SUBSTITUTION; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; RADIOACTIVE METABOLITES; TISSUE DISTRIBUTION; ARYL HALIDES; HUMAN PLASMA; BRAIN; WAY-100635; RADIOLIGAND;
D O I：
10.1016/j.ejmech.2014.07.096
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
N-(4-[F-18]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides were prepared by labeling their 4-nitropyridin-2-yl precursors through nitro substitution by the F-18 anion. In vitro and in vivo tests showed that the cyclohexanecarboxamide derivative is a reversible, selective and high affinity 5-HT1A receptor antagonist (IC50 = 0.29 nM, k(i) = 0.18 nM) with high brain uptake, slow brain clearance and stability to defluorination when compared with conventional standards. This PET radioligand is a promising candidate for an improved in vivo quantification of 5-HT1A receptors in neuropsychiatric disorders. (C) 2014 Published by Elsevier Masson SAS.
引用
收藏
页码：795 / 806
页数：12
相关论文
共 50 条
  • [21] [3H]4-(Dimethylamino)-N-[4-(4-(2-Methoxyphenyl)Piperazin-1-yl)Butyl]Benzamide, a Selective Radioligand for Dopamine D3 Receptors. I. In Vitro Characterization
    Xu, Jinbin
    Chu, Wenhua
    Tu, Zhude
    Jones, Lynne A.
    Luedtke, Robert R.
    Perlmutter, Joel S.
    Mintun, Mark A.
    Mach, Robert H.
    SYNAPSE, 2009, 63 (09) : 717 - 728
  • [22] N-(4-(4-(2,3-Dichloro- or 2-methoxyphenyl)piperazin-1-yl)butyl)heterobiarylcarboxamides with Functionalized Linking Chains as High Affinity and Enantioselective D3 Receptor Antagonists
    Newman, Amy Hauck
    Grundt, Peter
    Cyriac, George
    Deschamps, Jeffrey R.
    Taylor, Michelle
    Kumar, Rakesh
    Ho, David
    Luedtke, Robert R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (08) : 2559 - 2570
  • [23] N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide:: A potent and selective dopamine D4 ligand
    Perrone, R
    Berardi, F
    Colabufo, NA
    Leopoldo, M
    Tortorella, V
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (24) : 4903 - 4909
  • [24] 2-{4-[(1,3-Benzodioxol-5-yl)methyl]piperazin-1-yl}pyrimidine
    Wu, Chunli
    Li, Jieming
    Wei, Huijie
    Hang, Ye
    ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS, 2013, 69 : O1140 - +
  • [25] Parallel synthesis and dopamine D3/D2 receptor screening of novel {4-[4-(2-methoxyphenyl)piperazin-1-yl]butyl}carboxamides
    Heldler, P
    Zohrabi-Kalantari, V
    Calmels, T
    Capet, M
    Berrebi-Bertrand, I
    Schwartz, JC
    Stark, H
    Link, A
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (06) : 2009 - 2014
  • [26] (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl]benzenesulfonamide, a selective dopamine D-4 antagonist
    TenBrink, RE
    Bergh, CL
    Duncan, JN
    Harris, DW
    Huff, RM
    Lahti, RA
    Lawson, CF
    Lutzke, BS
    Martin, IJ
    Rees, SA
    Schlachter, SK
    Sih, JC
    Smith, MW
    JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (13) : 2435 - 2437
  • [27] Preparation and biodistribution of 99Tc-tricarbonyl complex with 4-[(2-methoxyphenyl)piperazin-1-yl]-dithioformate as a potential 5-HT1A receptor imaging agent
    Zhang, Xianzhong
    Zhou, Panwang
    Liu, Jiaojiao
    Huang, Yan
    Lin, Yan
    Chen, Yanlng
    Gu, Ting
    Yang, Wenjiang
    Wang, Xuebin
    APPLIED RADIATION AND ISOTOPES, 2007, 65 (03) : 287 - 292
  • [28] Synthesis, computational and pharmacological evaluation of novel N-{4-[2-(4-aryl-piperazin-1-yl)ethyl]phenyl}-arylamides
    Andric, Deana B.
    Dukic-Stefanovic, Sladjana
    Krunic, Mihajlo J.
    Jevtic, Ivana I.
    Penjisevic, Jelena Z.
    Sukalovic, Vladimir B.
    Kostic-Rajacic, Sladana
    JOURNAL OF THE SERBIAN CHEMICAL SOCIETY, 2024, 89 (03) : 291 - 303
  • [29] INSILICO STUDY OF N-(4-OXO-2-(4-(4-(2-(SUBSTITUTED PHENYL AMINO) ACETYL) PIPERAZIN-1-YL) PHENYL) QUINAZOLIN-3(4H)- YL) BENZAMIDE DERIVATIVES
    Priteshkumar, Patel
    Hirak, Joshi
    Bhagirath, Patel
    Mayank, Bapna
    PHARMACOPHORE, 2023, 14 (02): : 65 - 70
  • [30] In vitro tocolytic activity of 3-benzamido-1-(4-(2-methoxyphenyl)-piperazin-1-yl)-propyl-2-isopropylcarboxamide
    Okunrobo O. Lucky
    Owolabi J. Omonkhelin
    Pharmaceutical Chemistry Journal, 2009, 43 : 16 - 18
12345